Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Antibodies
Filter     Order     Display # 
Date Item Title
05 Jun 2008 Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma
04 Jun 2008 ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO
04 Jun 2008 Seattle Genetics Reports Multiple Complete and Partial Responses with SGN-35 in Patients with Lymphoma
04 Jun 2008 BioInvent and ThromboGenics report positive Phase I results for anti-PlGF cancer therapeutic TB-403
04 Jun 2008 Bradmer Receives FDA Approval to Proceed with Phase III Clinical Trial
03 Jun 2008 Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combination With Velcade for Multiple Myeloma
03 Jun 2008 Trubion Announces Presentation of Positive TRU-016 Data at ASCO
03 Jun 2008 New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing’s Sarcoma
03 Jun 2008 Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
03 Jun 2008 Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer
02 Jun 2008 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
02 Jun 2008 New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
02 Jun 2008 Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
02 Jun 2008 Interim Phase 2 Results of Open-Label Clinical Trial of Denosumab in Giant Cell Tumor of Bone Demonstrated 87 Percent Response Rate
02 Jun 2008 CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
30 May 2008 Merck Receives CHMP Positive Opinion for Marketing Authorization for Erbitux Including First-Line Colorectal Cancer in the European Union
30 May 2008 Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer
30 May 2008 Genmab initiates Zalutumunab combination study in Colorectal Cancer
28 May 2008 Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial Versus Weekly Alendronate (FOSAMAX(R))
28 May 2008 Ablynx Announces Initiation of a Phase Ib Study in Patients for ALX-0081 and Provides a Business Update for the First Quarter 2008
21 May 2008 Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week
21 May 2008 Sanofi-aventis and Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program in Oncology
21 May 2008 Cimzia(R) provides long-term efficacy with stable dosing in Crohn's disease
20 May 2008 Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
20 May 2008 Phase I/II Studies of IMC-A12 in Pancreatic Cancer Open for Patient Enrollment
19 May 2008 Patient recruitment started in Phase III registration trial with CA9-SCAN
19 May 2008 Schering-Plough Extends Antibody Alliance with MorphoSys
16 May 2008 ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
15 May 2008 Lpath's iSONEP(TM) IND Application Gets Green Light From FDA
13 May 2008 Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment
13 May 2008 Affimed validates antibody target for cancer metastasis
13 May 2008 Start of Phase II Clinical Study for Rabies Monoclonal Antibody Combination in the Philippines
13 May 2008 Active Biotech advances ANYARA into Phase III clinical trial
12 May 2008 Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
09 May 2008 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
08 May 2008 Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration
08 May 2008 Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
30 Apr 2008 Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis
29 Apr 2008 Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
29 Apr 2008 Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
28 Apr 2008 MorphoSys Announces Completion of First Dosing in Phase 1 Trial for MOR103 Program
28 Apr 2008 Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
28 Apr 2008 KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003
28 Apr 2008 Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
24 Apr 2008 ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24 Apr 2008 MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
23 Apr 2008 Micromet Enrolls First Patient in Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 101 - 150 of 1063

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics